Welding Fumes Health Monitoring: Obligations for Australian Employers

📋 Part of our complete series: Welding Fumes Assessment Australia: The Complete Guide

Welding Fumes Health Monitoring: Obligations for Australian Employers

Health monitoring is a legally mandated occupational health program for workers exposed to welding fume in Australia. Under Schedule 14 of the WHS Regulations, PCBUs with workers in roles where exposure to welding fume is unavoidable must establish and maintain health monitoring programs. These programs detect early signs of welding fume-related disease and fulfil the PCBU’s duty of care. Yet many Australian workplaces remain unclear about what health monitoring is, when it is required, and how to implement it correctly. For more information, see our guide to chemical hazards and workplace exposure standards.

This article explains the regulatory framework, the clinical components of health monitoring for welders, and practical implementation guidance for Australian employers.

Health Monitoring vs. Health Surveillance: Understanding the Difference

The terms “health monitoring” and “health surveillance” are sometimes used interchangeably, but they have distinct meanings under Australian occupational health law:

Health Surveillance is ongoing observation of the health of workers in roles where exposure hazards are known. It may include informal health checks, questionnaires, and review of workers’ compensation claims—but it is not necessarily clinical assessment.

Health Monitoring is a formal, structured program of clinical assessment (typically spirometry, biological monitoring, and clinical review) designed to detect early signs of work-related disease. Health monitoring is measured, recorded, and formally reviewed by an occupational health professional.

Under Schedule 14 of the WHS Regulations, PCBUs must establish health monitoring programs (not merely surveillance) for workers exposed to specified hazardous substances or processes. Welding fume is one of the listed hazards.

Legal Obligation: Schedule 14, WHS Regulations

Schedule 14 specifies hazardous substances and work-related processes for which health monitoring must be provided. The entry for “Welding (fume)” reads: Learn more about stainless steel welding fumes hazards in our detailed guide.

“Welding (fume) — health monitoring must include spirometry and biological monitoring where applicable.”

The Schedule does not specify a minimum exposure threshold above which monitoring must be initiated. However, Safe Work Australia’s Code of Practice: Welding Processes 2021 states that health monitoring should be offered to workers where exposure cannot be controlled below approximately 0.5 mg/m³ (8-hour TWA) despite implementation of engineering and administrative controls.

The PCBU’s obligation is to:

Identify workers who require health monitoring based on exposure assessment.
Offer health monitoring as part of the worker’s employment conditions.
Ensure monitoring is conducted by a competent occupational health provider.
Retain records of all health monitoring for a minimum of 30 years.
Inform workers of health monitoring results and act on abnormal findings.
Maintain confidentiality of health data (separate from personnel records).

Components of Welding Fumes Health Monitoring

1. Pre-employment Spirometry and Questionnaire

Before a worker begins welding or enters a role with welding fume exposure, baseline respiratory function must be measured. Spirometry measures forced expiratory volume in 1 second (FEV₁), forced vital capacity (FVC), and the FEV₁/FVC ratio. This establishes a baseline against which future results can be compared.

A comprehensive occupational health questionnaire is also completed, capturing:

Respiratory symptoms (cough, phlegm, wheeze, breathlessness).
Smoking history.
Prior occupational exposures.
Medical history (asthma, allergies, lung disease).
Current medications.
Detailed welding history (how long welding, which processes, which materials).

The pre-employment assessment establishes whether the worker has pre-existing respiratory disease or other health issues that might be exacerbated by welding fume exposure. In some cases, workers with severe asthma or COPD may not be suitable for welding roles.

2. Spirometry: How It Works and What It Detects

Spirometry is the primary respiratory function test used in health monitoring for welders. A trained technician asks the worker to breathe into a spirometer—a device that measures the volume and flow rate of air during breathing.

Key measurements include:

FEV₁ (Forced Expiratory Volume in 1 second): The volume of air the worker can forcefully exhale in the first second. Welding fume exposure, particularly to stainless steel welding, is associated with reduced FEV₁ over time.
FVC (Forced Vital Capacity): The total volume of air that can be forcefully exhaled after maximal inhalation.
FEV₁/FVC Ratio: A ratio below 0.70 suggests airflow obstruction (chronic obstructive pulmonary disease, COPD, or asthma).

Abnormal patterns in welders include:

Obstructive pattern: Reduced FEV₁/FVC ratio, consistent with airways disease (welders exposed to stainless steel or high-manganese consumables).
Restrictive pattern: Reduced FVC, suggesting interstitial lung disease or chest wall stiffness (less common in welders, but seen in some heavy exposures).

Spirometry is typically repeated annually for workers with ongoing welding fume exposure. A decline in FEV₁ of more than 15% in a single year, or a cumulative decline exceeding 5% per year, is considered significant and requires investigation.

3. Biological Monitoring: Metals in Blood and Urine

Biological monitoring measures the concentration of metals (manganese, chromium, nickel, and others) in workers’ blood or urine. These measurements reflect recent and cumulative exposure to welding fume metals.

Common biological monitoring analytes for welders include:

Blood Manganese (Mn): Reflects recent exposure (2–3 weeks). Elevated blood Mn is associated with neurotoxic effects. Reference ranges are typically 3–15 µg/L, but occupational health providers may recommend investigation if levels exceed 25 µg/L.
Urinary Chromium (Cr): For stainless steel welders, urinary Cr reflects exposure to chromium, including hexavalent chromium (Cr(VI)). Reference ranges vary, but values above 10 µg/L warrant review.
Urinary Nickel (Ni): For nickel-containing stainless steel. Elevated urinary Ni is associated with respiratory and dermatological effects.
Blood Lead: If welding on painted structures (lead-containing paint) or using lead-containing solder.

Biological monitoring is typically conducted annually or more frequently if exposure levels are high or if previous results show elevated levels.

4. Neurotoxicity Screening

Because welding fume exposure (particularly to manganese) is associated with neurological effects (Parkinson’s-like syndrome, tremor, cognitive decline), some occupational health providers include cognitive and motor function screening in health monitoring programs. This might involve simple screening questionnaires or referral to neurology specialists if there are concerns.

Health Monitoring Program Design and Implementation

A comprehensive health monitoring program for welders should include the following elements:

Step 1: Exposure Assessment
Conduct air monitoring to quantify welding fume exposure for each worker group (similar exposure group, or SEG). As noted above, health monitoring is typically initiated when exposure cannot be controlled below approximately 0.5 mg/m³.

Step 2: Worker Identification and Consent
Identify all workers who meet the criteria for health monitoring. Provide written information about the program, explaining the purpose, what tests will be conducted, how results will be reported, and their rights. Obtain informed consent before initiating monitoring.

Step 3: Select an Occupational Health Provider
Engage a medical practice or occupational health clinic experienced in occupational health monitoring for welders. The provider should be accredited or certified (Australian Society of Occupational Medicine, AIOH, etc.). Ensure they understand your workplace, the specific welding processes, and exposure levels.

Step 4: Pre-employment Baseline Assessment
Conduct baseline spirometry and biological monitoring before the worker is first exposed to welding fume. Ensure baseline results are reviewed and documented before the worker begins welding work.

Step 5: Periodic Monitoring Schedule
Establish a monitoring schedule. Annual monitoring is standard for workers with ongoing welding fume exposure. More frequent monitoring (e.g., 6-monthly) may be warranted if exposure is particularly high or if previous results showed concerning trends.

Step 6: Results Review and Action Protocol
Define how results will be reviewed and communicated. Establish clear action thresholds—for example:

If FEV₁ declines by more than 15% in one year: refer for specialist respiratory assessment, review control measures, and consider role modification.
If blood Mn exceeds 30 µg/L: review exposure assessment, enhance controls, and conduct more frequent monitoring (e.g., 6-monthly).
If neurological symptoms are reported: refer to occupational medicine specialist and neurologist.

Step 7: Record Keeping
Maintain comprehensive records of all health monitoring data. Records must be kept separate from personnel records and must remain confidential. Records must be retained for a minimum of 30 years (the working lifetime of a welder plus retirement).

Step 8: Exit Monitoring
When a worker leaves employment or transitions out of a welding role, conduct exit spirometry and biological monitoring. This captures the cumulative effect of exposure during their time in the role and provides a final baseline in case future health issues arise.

Pre-employment vs. Periodic vs. Exit Monitoring

Three phases of health monitoring apply to welders:

Pre-employment Monitoring: Conducted before the worker begins welding work (or before entering a role with significant new exposure). Establishes baseline respiratory and biological status. If pre-employment spirometry reveals significant airways obstruction (FEV₁/FVC < 0.70), the worker may not be suitable for welding work, particularly if the obstruction is progressive.

Periodic Monitoring: Conducted at regular intervals (typically annually) during the worker’s tenure in a welding role. Detects changes in respiratory function, metal burden, or other health markers that might indicate excessive exposure or early disease.

Exit Monitoring: Conducted when the worker leaves the role (e.g., retirement, job change, redeployment). Captures a final snapshot of respiratory function and metals burden after the cumulative exposure period. This monitoring is important for future medical assessment if the worker develops health issues years later; the exit monitoring data provides evidence of baseline function at the time of leaving.

Managing Abnormal Results

If health monitoring reveals abnormal results, a systematic response is required:

Step 1: Notify the Worker
Inform the worker of the abnormal result in plain language. Explain what the result means, what it may indicate, and what follow-up is planned. Provide a copy of the report. Do not alarm the worker unnecessarily, but be transparent.

Step 2: Specialist Referral
Depending on the abnormality, refer the worker for specialist assessment—respiratory physician (for spirometry abnormalities), neurologist (for neurological signs), or occupational medicine physician (for overall assessment and management).

Step 3: Exposure Review
Review the worker’s exposure assessment. If abnormal results suggest exposure is not being controlled adequately, conduct additional air monitoring and re-evaluate control measures. This may reveal that exposures are higher than previously measured or that a particular process or material is contributing disproportionately to exposure.

Step 4: Control Measures Enhancement
If abnormal results are attributed to excessive exposure, enhance controls immediately. This may involve upgrading local exhaust ventilation, changing welding consumables to lower-manganese alternatives, or modifying the worker’s exposure (e.g., job rotation to reduce hours in high-exposure roles).

Step 5: Increased Monitoring Frequency
Increase monitoring frequency to 6-monthly or quarterly (as recommended by the occupational health provider) to detect further deterioration early.

Step 6: Documentation and Communication
Document the abnormal result, the action taken, and the outcome in the worker’s health monitoring file. Notify the regulator if required (e.g., if the abnormality represents a notifiable incident or if the worker’s condition may require medical leave).

Health Monitoring Records: 30-Year Retention

The WHS Regulations require PCBUs to retain health monitoring records for at least 30 years. This reflects the latency period for occupational diseases related to welding fume (particularly lung cancer and neurological disease can take 20–30 years to manifest).

Records must include:

Pre-employment and periodic spirometry results (raw data, not just summaries).
Biological monitoring results (blood and urine metals).
Occupational health questionnaire responses.
Clinical notes and recommendations from the occupational health provider.
Records of communications with the worker regarding results.
Records of any action taken (exposure review, control enhancement, specialist referral).

Records must be stored securely and separately from personnel records. Access must be restricted to the occupational health provider, relevant PCBU senior management, and the worker themselves (upon request).

Many PCBUs now use electronic health record systems designed for occupational health data. These systems allow secure storage, automated trending of results over time, and generation of reports for regulatory inspection.

Frequently Asked Questions

Q1: At what exposure level must health monitoring be initiated?
A: Safe Work Australia’s guidance indicates that health monitoring should be offered when exposure cannot be controlled below approximately 0.5 mg/m³ (8-hour TWA). However, some occupational health providers recommend offering monitoring to all workers with measurable welding fume exposure (any level above background), as this provides a conservative approach and captures early trends. Air monitoring is the first step in determining whether health monitoring is required.

Q2: Can a worker refuse health monitoring?
A: A worker cannot legally refuse health monitoring if they are in a role requiring it under Schedule 14. However, a worker can request that certain tests be deferred if they have specific health concerns (e.g., not suitable for spirometry due to recent respiratory infection). The worker must understand that refusal to participate in health monitoring may impact their continued employment in the welding role, as the PCBU cannot ensure their health is being protected without monitoring data.

Q3: Are health monitoring results confidential?
A: Yes. Health monitoring records are medical information and must be treated as confidential. They must be held separately from personnel records and must not be shared with supervisors, HR, or other workers without the worker’s explicit consent. The PCBU can be notified that a worker requires action (e.g., enhanced controls, role modification) based on health results, but specific health details must not be disclosed.

Q4: What happens if a worker’s spirometry shows declining lung function?
A: The occupational health provider will typically recommend investigation by a respiratory physician to clarify the pattern (obstructive vs. restrictive) and to rule out other causes (smoking, asthma, unrelated lung disease). If the decline is attributed to welding fume exposure, control measures should be enhanced, exposure should be reduced (via job rotation or process change), and monitoring frequency should be increased. In some cases, the worker may need to be redeployed to a non-welding role if the decline is severe and appears to be accelerating.

Q5: Do workers with high biological monitoring results (e.g., elevated blood manganese) have different health risks than workers with normal results?
A: Elevated biological monitoring results indicate higher recent exposure to metals. While no exposure-response relationship has been definitively established at occupational exposure levels, elevated results warrant investigation and enhanced controls. Some research suggests that elevated blood manganese may be associated with increased neurological risk, though this remains an active area of occupational health research. At minimum, elevated results justify enhanced exposure control and more frequent monitoring.

Q6: How should a PCBU handle an older worker with a long history of welding fume exposure who declines to participate in health monitoring?
A: This is a challenging scenario. The PCBU cannot legally allow the worker to continue welding without participation in health monitoring (as the PCBU would be failing its duty of care). The PCBU should engage the worker in a respectful conversation, explain why monitoring is necessary, and explore any barriers (fear of results, distrust of medical professionals, cultural concerns). In some cases, engaging an occupational health provider who speaks the worker’s language or shares cultural background may help. If the worker continues to decline, the PCBU may need to consider role redeployment as a last resort, but this should only occur after all other options have been exhausted.

Integration with Exposure Control

Health monitoring is not a substitute for exposure control. WES compliance requires that exposure be controlled to 1 mg/m³ (or preferably below 0.5 mg/m³) through engineering and administrative controls first. Health monitoring is an additional layer of protection—it detects early signs of harm in workers who cannot be fully protected through controls and prompts further action (enhanced controls, role modification, medical leave if necessary).

A well-designed health monitoring program demonstrates to workers, regulators, and potential future claimants that the PCBU takes worker health seriously and is actively monitoring for early signs of disease.

Request a Health Monitoring Program Design Quote